tezosentan has been researched along with Hypoxia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anger, KE; Lagambina, S; Nuccio, P; Szumita, PM; Torbic, H; Weinhouse, G | 1 |
| Fischer, V; Geiger, R; Kleinsasser, A; Loeckinger, A; Neu, N; Stein, JI; Treml, B | 1 |
| Hedelin, P; Kylhammar, D; Rådegran, G | 1 |
| Hedelin, P; Kylhammar, D; Lundgren, J; Rådegran, G | 1 |
| Hlastala, MP; Lamm, WJ; Neradilek, B; Polissar, NL; Tsang, JY | 1 |
5 other study(ies) available for tezosentan and Hypoxia
| Article | Year |
|---|---|
Clinical and Economic Impact of Formulary Conversion From Inhaled Flolan to Inhaled Veletri for Refractory Hypoxemia in Critically Ill Patients.
Topics: Administration, Inhalation; Adult; Aged; Critical Illness; Epoprostenol; Female; Humans; Hypoxia; Intensive Care Units; Length of Stay; Male; Middle Aged; Pyridines; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Retrospective Studies; Tetrazoles; Time Factors; Vasodilator Agents | 2016 |
Intravenous tezosentan and vardenafil attenuate acute hypoxic pulmonary hypertension.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Imidazoles; Injections, Intravenous; Male; Piperazines; Pulmonary Gas Exchange; Pyridines; Random Allocation; Sulfones; Swine; Tetrazoles; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2008 |
Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Female; Heart Rate; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; Pulmonary Artery; Pyridines; Receptor, Endothelin A; Receptor, Endothelin B; Swine; Tetrazoles; Time Factors; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2012 |
sGC stimulation totally reverses hypoxia-induced pulmonary vasoconstriction alone and combined with dual endothelin-receptor blockade in a porcine model.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin Receptor Antagonists; Enzyme Activators; Female; Guanylate Cyclase; Hypertension, Pulmonary; Hypoxia; Lung; Morpholines; Pyridines; Pyrimidines; Receptors, Endothelin; Swine; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilator Agents | 2012 |
Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism.
Topics: Acute Disease; Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Hypoxia; Imaging, Three-Dimensional; Lung; Microspheres; Pulmonary Embolism; Pulmonary Gas Exchange; Pulmonary Ventilation; Pyridines; Receptors, Endothelin; Regional Blood Flow; Swine; Tetrazoles; Vasodilator Agents; Ventilation-Perfusion Ratio | 2007 |